triaziquone has been researched along with Anemia, Hemolytic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MAUSS, HJ | 1 |
| Strubelt, O | 1 |
2 other study(ies) available for triaziquone and Anemia, Hemolytic
| Article | Year |
|---|---|
[ERYTHROPOIETIN PRODUCTION AND THE EFFECTS OF ERYTHROPOIETIN ON ERYTHROPOIESIS INHIBITION BY CYTOSTATIC DRUGS)].
Topics: Anemia; Anemia, Hemolytic; Antineoplastic Agents; Cytostatic Agents; Epoetin Alfa; Erythropoiesis; Erythropoietin; Pharmacology; Rats; Research; Triaziquone | 1964 |
[Life expectancy of erythrocytes under the influence of the cytostatic 2,3,5-tris-ethyleniminobenzoquinone-(1,4) and the anabolic methenolone enanthate].
Topics: Alkylating Agents; Anemia, Hemolytic; Animals; Azirines; Blood Proteins; Erythrocyte Aging; Erythropoiesis; In Vitro Techniques; Methenolone; Rats; RNA; Triaziquone | 1965 |